Uro-BCG
(40 mg)
(one)
(Bottle)
Onco-BCG 40 mg one doses, India
In Stock
Showing before stagnation.
The drug is indicated for the treatment of: Non-invasive urothelial carcinoma of the mikhur: - treatment of carcinoma in situ;
- preventive treatment of relapses: urothelial carcinoma that has affected the mucous membrane; that G1-G2, if the swelling is multifocal/or recurrent; that G3; urothelial carcinoma in lamina propria, if there is no infection of the flesh tissue of the fur (TI); carcinoma in situ.
Method of administration and dosage.
Dozuvannya.
Instead of 1 bottle, an adult is enough for one instilation of sechovy mikhur
-
Commercial name:Uro-BCG
-
Dosage:40 mg
-
Quantity:one
-
Release form:Bottle
No reviews yet